Greenleaf Peter
SEC Form 4 insider trading activity
Greenleaf Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 2 companies, including PTHS, AUPH, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 7, 2026.
On the most recent filing, Greenleaf Peter is listed as Director at Pelthos Therapeutics Inc. Inside the rolling window, Greenleaf Peter reported no open-market purchases and 2 open-market sales totaling $37K in PTHS. The largest disclosed transaction in the window is a sale of 797 PTHS shares on Jul 2, 2026, worth $21K.
Companies traded
Other insiders at PTHS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$37K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Greenleaf Peter made?
Greenleaf Peter has filed 6 SEC Form 4 filings (10 transaction rows) across 2 companies, including PTHS, AUPH since 2026.
Which companies does Greenleaf Peter trade?
Greenleaf Peter has filed SEC Form 4 disclosures for 2 companies, including PTHS, AUPH.
When was Greenleaf Peter's most recent SEC Form 4 filing?
Greenleaf Peter's most recent SEC Form 4 filing on Tracefour is dated Jul 7, 2026.
What is Greenleaf Peter's total buy and sell value in the current window?
Inside the rolling retention window, Greenleaf Peter bought $0 and sold $37K based on SEC Form 4 filings.
What was Greenleaf Peter's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 797 PTHS shares on 2026-07-02, worth $21K, per SEC Form 4 filings.